Uirusu
Online ISSN : 1884-3433
Print ISSN : 0042-6857
ISSN-L : 0042-6857
Volume 67, Issue 1
Displaying 1-9 of 9 articles from this issue
Special Issue: Measles Virus
  • Maino TAHARA, Makoto TAKEDA
    2017Volume 67Issue 1 Pages 3-16
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    Measles virus (MeV) is exceptionally contagious and still a major cause of death in child.However, recently significant progress towards the elimination of measles has been made through increased vaccination coverage of measles-containing vaccines. The hemagglutinin (H) protein of MeV interacts with a cellular receptor, and this interaction is the first step of infection. MeV uses two different receptors, signaling lymphocyte activation molecule (SLAM) and nectin-4 expressed on immune cells and epithelial cells, respectively. The interactions of MeV with these receptors nicely explain the immune suppressive and high contagious properties of MeV. Binding of the H protein to a receptor triggers conformational changes in the fusion (F) protein, inducing fusion between viral and host plasma membranes for entry. The stalk region of the H protein plays a key role in the F protein-triggering. Recent studies of the H protein epitopes have revealed that the receptor binding site of the H protein constitutes a major neutralizing epitope. The interaction with two proteinaceous receptors probably imposes strong functional constraints on this epitope for amino acid changes. This would be a reason why measles vaccines, which are derived from MV strains isolated more than 60 years ago, are still highly effective against all MV strains currently circulating.
    Download PDF (3073K)
  • Keiko TANAKA-TAYA
    2017Volume 67Issue 1 Pages 17-24
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    A large-scale national measles epidemic occurred among mainly in teenagers and young adults in 2007. MHLW announced ''Special infectious disease prevention guidelines for measles'' (issued on 28 December 2007; Revised issued on 30 March 2013), and Japan decided the elimination target year was fiscal year (FY) 2015. In 2008, it continued to be a large-scale nation epidemic exceeding 10,000 cases, and a large number of 0 to 1 year old infants, teenagers and young adults were suffering. Many cases were unvaccinated, single dose vaccination or unknown vaccination history. The number of measles cases has declined dramatically since 2009, and the measles virus of genotype D5, which was the indigenous strain in Japan, was not detected at the end of May 2010. Regional epidemics were approved in 2011 and 2014, starting from imported cases from overseas, but it ended early. Since 2006, a two-dose routine vaccination regimen of measles rubella combined (MR) vaccine has started, moreover in the 5 years from fiscal 2008, the second dose of MR vaccine for junior high school students and high school students was periodically inoculated and immunization strengthened for teens was done. As a result, antibody positive rate of 95% or more is maintained in all age groups over 2 years old. In March 2015, Japan's measles elimination was certified by the WHO Western Pacific Regional Office. In 2017, outbreaks occurred in adults originating from imported cases from Asia or Europe, but early termination declarations have been made by aggressive measures by local public health centers/institutes. The annual number of reported cases after measles elimination certification is less than 200 cases.
    Download PDF (2329K)
Topics 1: Coexistence of viruses in our society
  • Hiroaki KARIWA
    2017Volume 67Issue 1 Pages 25-32
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    Hantaviruses belongs to the genus Hantavirus in the family Bunyaviridae are maintained in rodents and infects to humans by inhalation of the aerosol of infected rodent excreta. In this article, the epidemiology of hantavirus infection and the special relationship between rodent and hantavirus are described. Hantavirus infections include hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). HFRS is characterized high fever, hemorrhage, and renal disorder. HFRS is distributed in East Asia, Europe, and Russia. While HCPS is characterized acute respiratory dysfunction and cardiogenic shock. The distribution of HCPS is limited in North and South Americas. In Japan's neighboring countries, such as Russia, China, and Korea, large numbers of HFRS patients are reported in association with multiple hantaviruses. In Japan, hantavirus infection has not been reported since 1985 but grey red-backed vole (Myodes rufocanus bedfordiae) inhabiting Hokkaido maintain one of the hantaviruses. Coevolution between hantavirus and host may have been occurred during a long period. The endemic areas of hantavirus infection are strongly associated with the distribution of host animal carrying pathogenic hantaviruses.
    Download PDF (729K)
  • Yuko FUJIGAKI
    2017Volume 67Issue 1 Pages 33-34
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
Topics 2: Plant viruses recently identified in fields and gardens
SUGIURA Memorial Incentive Award for Young Virologist, The Japanese Society for Virology, 2016
  • Toru OKAMOTO
    2017Volume 67Issue 1 Pages 49-58
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    Hepatitis C virus (HCV) is a blood-borne virus and causes chronic infection leading to development of steatosis, cirrhosis and hepatocellular carcinoma. However, molecular mechanisms of induction of liver diseases by HCV infection are still unclear. This review focuses on thevirological significance of processing of HCV core protein by signal peptide peptidase in propagation and pathogenesis of HCV.
    Download PDF (3596K)
  • Atsushi KAWAGUCHI
    2017Volume 67Issue 1 Pages 59-68
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    For efficient replication of the influenza virus genome and its post-replicational processes, not only viral factors but also host-derived cellular factors (host factors) are required. The influenza virus genome exists as viral ribonucleoprotein (vRNP) complexes with viral RNA-dependent RNA polymerases and nucleoprotein (NP). Using biochemical and proteomics approaches, we have identified host factors which are required for the vRNP replication and the progeny vRNP transport. We found that MCM complex, a cellular DNA replication licensing factor, is required for successful viral genome replication. In concert with the replication reaction, the nascent RNA chains are encapsidated with NP by cellular splicing factor UAP56. Further, after nuclear export of vRNP, we revealed that vRNP is transported to the plasma membrane using cholesterol-enriched recycling endosomes through cell cycle-independent activation of the centrosome by YB-1, which is a mitotic centrosomal protein. Depletion of YB-1 shows that the cholesterol-enriched endosomes are important for clustering of viral structural proteins at lipid rafts to assemble the virus particles concomitantly with the arrival of vRNP beneath the plasma membrane.
    Download PDF (1719K)
  • Takao HASHIGUCHI
    2017Volume 67Issue 1 Pages 69-78
    Published: June 25, 2017
    Released on J-STAGE: March 29, 2018
    JOURNAL FREE ACCESS
    Mononegaviruses are non-segmented negative-strand RNA viruses, and include measles, mumps, Marburg, and Ebola viruses. Measles virus and mumps virus, members of the family Paramyxoviridae, are immunotropic and neurotropic, respectively. Marburg virus and Ebola virus, members of the family Filoviridae, cause highly lethal hemorrhagic fever. In this paper, I summarize the recent structural and functional studies on the viral glycoproteins (GPs) of these viruses, which have shed light on virus entry and the humoral response. The structural and functional analyses of the interaction between viral GPs and receptors/antibodies also illuminate directions toward therapeutics against the viruses.
    Download PDF (3828K)
feedback
Top